Skip to main content
Log in

Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells

  • Published:
Clinical & Experimental Metastasis Aims and scope Submit manuscript

Human colon cancer (Moser) cells produce and secrete epidermal growth factor (EGF) and respond to EGF via an autocrine/paracrine mode through the cell surface EGF receptor (EGFR). In this report we show that EGF promotes the malignant behavior of the Moser cells in vitro in terms of growth in soft agarose and invasion of Matrigel-coated porous membranes. Expressing antisense EGFR RNA in the Moser cells (through transfection with an inducible antisense EGFR expression vector) downmodulated the expression of cell surface EGFR and EGFR mRNA with a concurrent inhibition of growth in soft agarose and invasion of Matrigel-coated membranes. In addition, the ability of exogenously applied EGF in promoting the malignant behavior of these cells was circumvented. We conclude that antisense EGFR RNA was a potent agent in circumventing the f malignant properties of the Moser cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cross M and Dexter TM, 1991, Growth factors in development, transformation and tumorigenesis. Cell, 64, 271–80.

    Google Scholar 

  2. Kerbel RS, 1993, Growth factors as mediators of malignant tumor progression. Cancer Metastasis Rev, 12, 215–17.

    Google Scholar 

  3. Donaldson RW, Nishibe S and Carpenter G, 1989, The tructure and physiology of epidermal growth factor and its receptor. In: Minter EE, Cocchi D and Locatelli V eds, Advances in Growth Hormone and Growth Factor Research, Rome: Pythagora Press; Berlin: Springer-Verlag, pp. 165–180

    Google Scholar 

  4. Huang S, Lin P-F, Fan D, et al. 1991, Growth modulation by epidermal growth factor (EGF) in human colonic carcinoma cells: constitutive expression of the human EGF gene. J Cell Physiol, 148, 220–7.

    Google Scholar 

  5. Huang S, Trujillo J and Chakrabarty S, 1992, Proliferation of human colon cancer cells: role of epidermal growth factor and transforming growth factor α. Int J Cancer, 52, 978–86.

    Google Scholar 

  6. Stern DF, Hare DL, Cecchini MA and Weinberg RA, 1987, Construction of a novel oncogene based on synthetic sequences encoding epidermal growth factor. Science, 235, 321–4.

    Google Scholar 

  7. Cartlidge SA and Elder JB, 1989, Transforming growth factor α and epidermal growth factor levels in normal human gastrointestinal mucosa. Br J Cancer, 60, 657–60.

    Google Scholar 

  8. Tanaka S, Imanishi K-I and Haruma K, 1992, Immunoreactive transforming growth factor α and epidermal growth factor in colorectal adenomas and carcinomas. Oncology, 49, 381–5.

    Google Scholar 

  9. Borlinghaus P, Wieser S and Lamerz R, 1993, Epidermal growth factor, transforming growth factor α, and epidermal growth factor receptor content in normal and carcinomatous gastric and colonic tissue. Clin Invest, 71, 903–7.

    Google Scholar 

  10. Karameris A, Kanavaros P, Aninos D, etal, 1993, Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas: an immunohistological study of 63 cases. Path Res Pract, 189, 133–7.

    Google Scholar 

  11. Ito M, Yoshida K, Kyo E, et al. 1990, Expression of several growth factors and their receptor genes in human colon carcinomas. Virchows Archiv B Cell Pathol, 59, 173–8.

    Google Scholar 

  12. Ullrich A, Coussens L, Hayflick JS, et al. 1984, Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature, 309, 418–23.

    Google Scholar 

  13. Huang S, Varani J and Chakrabarty S, 1994, Control of AKR fibroblast phenotype by fibronectin: regulation of cell-surface fibronectin binding receptor by fibronectin. J Cell Physiol, 161, 470–82.

    Google Scholar 

  14. Karin M, Haslinger A, Holtgreve, et al. 1984, Activation of a heterologous promoter in response to dexamethasone and cadmium by metallothionein gene 5′-flanking DNA. Cell, 36, 371–9.

    Google Scholar 

  15. Brattain MG, Levine AE, Chakrabarty S, 1984, Heterogeneity of human colon carcinoma. Cancer Metastasis Rev, 3, 177–91.

    Google Scholar 

  16. Chakrabarty S, Fan D and Varani J, 1990, Modulation of differentiation and proliferation in human colon carcinoma cells by transforming growth factor 1 and β2. Int J Cancer, 46, 493–9.

    Google Scholar 

  17. Dean CJ, Modjtahedi H, Eccles S, Box G and Styles J, 1994, Immunotherapy with antibodies to the EGF receptor. Int J Cancer, S8, 103–7.

    Google Scholar 

  18. Arteaga CL, Hurd SD, Dugger TC, Winnier AR and Robertson JB, 1994, Epidermal growth factor receptors in human breast carcinoma cells: a potential selective target for transforming growth factor α-Pseudomonas exotoxin 40 fusion protein. Cancer Res, 54, 4703–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chakrabarty, S., Rajagopal, S. & Huang, S. Expression of antisense epidermal growth factor receptor RNA downmodulates the malignant behavior of human colon cancer cells. Clin Exp Metast 13, 191–195 (1995). https://doi.org/10.1007/BF00132207

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00132207

Keywords

Navigation